Friday, November 4, 2016

AbbVie Receives FDA Orphan Drug Designation for Investigational Medicine Veliparib for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer

… of advanced squamous non-small cell lung cancer (NSCLC).
PARP is a naturally-occurring … CancerNon-small cell lung cancer (NSCLC) is the most common type of lung cancer in … squamous and non-squamous non-small cell lung cancer (NSCLC), ovarian cancer and breast …

No comments:

Post a Comment